Autologous Stem Cell Rescue for Primary Amyloidosis
Completed · Phase 2
Conditions studied: Amyloidosis, Blood and Marrow Transplant (BMT)
In brief
To evaluate the role of high dose therapy and autologous hematopoietic cell transplant for amyloidosis.
Key facts
- Study ID
- NCT00186407
- Run by
- Stanford University
- People needed
- 50
- Starts
- 1998-04-01
- Expected to finish
- 2010-02-01
- Last updated by the study team
- 2010-09-14
Who can join
Age: 18 and older, up to 75. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Stanford University School of Medicine — Stanford, California, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.